Bliss GVS Pharma Ltd Performance
Day's Low
Day's High
₹119.77₹131.452 Week's Low
52 Week's High
₹92.15₹149.6
| Returns % | |
| 1 Month Return | -8.4 % |
| 3 Month Return | -5.18 % |
| 1 Year Return | -12.98 % |
| Market Stats | |
| Previous Close | ₹120.66 |
| Open | ₹121.74 |
| Volume | 30.35L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,270.57Cr |
Bliss GVS Pharma Ltd Key Statistics
| P/E Ratio | 19.98 |
| PEG Ratio | -8.15 |
| Market Cap | ₹1,270.57 Cr |
| P/B Ratio | 1.19 |
| EPS | 7.79 |
| Dividend Yield | 0.44 |
| Sector | Pharmaceuticals |
| ROE | 7.91 |
Bliss GVS Pharma Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,270.57 Cr | -2.53% | 0.54 | ₹81 Cr | ₹770 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Bliss GVS Pharma Ltd
Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.
To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.
Share Price: ₹129.06 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹1,270.57Cr as of today
Revenue: ₹217.68Cr as on September 2024 (Q3 24)
Net Profit: ₹25.69Cr as on September 2024 (Q3 24)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
| Organisation | Bliss GVS Pharma Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Bliss GVS Pharma Ltd
Bliss GVS Reports Mixed Financial Results for September - 28 Oct, 2024
Bliss GVS Pharma reported a 6.61% increase in standalone net sales for September 2024, but net profit fell 49.71%. Consolidated results showed a similar trend with a 42.66% profit decline.
Insights on Bliss GVS Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 187.77 Cr → 222.72 Cr (in ₹), with an average increase of 15.7% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 45.27% to 46.49% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -9.15 Cr → 24.26 Cr (in ₹), with an average increase of 79.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 71.5%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 107.5%
NEGATIVE IMPACTPrice Dip
In the last 1 year, BLISSGVS stock has moved down by -13.0%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 13.25% to 12.13% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 34.90% to 34.82% in Sep 2024 quarter
Bliss GVS Pharma Ltd Financials
Index Inclusions
Bliss GVS Pharma Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.82% | ||
| Foreign Institutions | 12.13% | ||
| Mutual Funds | 0% | 100.00 | |
| Retail Investors | 46.49% | 2.69 | |
| Others | 6.56% |
Bliss GVS Pharma Ltd Key Indicators
Bliss GVS Pharma Ltd Valuation
Bliss GVS Pharma Ltd in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (19.98x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (576.11x)
January 3, 2022
Bliss GVS Pharma Ltd Earnings and Dividends
Bliss GVS Pharma Ltd Earnings Results
Bliss GVS Pharma Ltd’s net profit fell -42.66% since last year same period to ₹24.26Cr in the Q2 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated 17.2% jump in its net profits since last 3-months.
Read More about Earnings ResultsBliss GVS Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.77%.
Read More about Dividends
Bliss GVS Pharma Ltd Technicals Summary
Bearish
Neutral
Bullish
Bliss GVS Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Bliss GVS Pharma Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Bliss GVS Pharma Ltd shares.
Bliss GVS Pharma Ltd (BLISSGVS) share price today is ₹129.06
Bliss GVS Pharma Ltd is listed on NSE
Bliss GVS Pharma Ltd is listed on BSE
- Today’s highest price of Bliss GVS Pharma Ltd is ₹131.4.
- Today’s lowest price of Bliss GVS Pharma Ltd is ₹119.77.
PE Ratio of Bliss GVS Pharma Ltd is 19.98
PE ratio = Bliss GVS Pharma Ltd Market price per share / Bliss GVS Pharma Ltd Earnings per share
Today’s traded volume of Bliss GVS Pharma Ltd(BLISSGVS) is 30.35L.
Today’s market capitalisation of Bliss GVS Pharma Ltd(BLISSGVS) is ₹1270.57Cr.
| Bliss GVS Pharma Ltd(BLISSGVS | Price |
|---|---|
52 Week High | ₹149.6 |
52 Week Low | ₹92.15 |
Bliss GVS Pharma Ltd(BLISSGVS) share price is ₹129.06. It is down -13.73% from its 52 Week High price of ₹149.6
Bliss GVS Pharma Ltd(BLISSGVS) share price is ₹129.06. It is up 40.05% from its 52 Week Low price of ₹92.15
| Bliss GVS Pharma Ltd(BLISSGVS | Returns |
|---|---|
1 Day Returns | 8.4% |
1 Month Returns | -8.4% |
3 Month Returns | -5.18% |
1 Year Returns | -12.98% |